“I had been playing with ideas on how to enhance the dispersability of this molecule for a number of years,” said Perlman, who has more than 100 patents and pending patents on inventions he has made ...

Empyrean Therapeutics acquires TLR-2 antagonist molecule from Eos Therapies to advance and commercialize breakthrough cancer treatment: Boca Raton, Florida Wednesday, November 27, ...

Daewoong Pharmaceutical announced Tuesday that it has filed for a domestic patent for a new obesity drug that suppresses ...